Anika Therapeutics (ANIK) Tops Q4 EPS by 28c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq eyes lower open after midterms-fueled surge as chip, data center stocks fall
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Apple seeks to raise up to $7 billion in seven-tranche bond offering
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
Tweet
Share
E-mailGet Alerts ANIK Hot Sheet
Price: $20.40 --0%
Revenue Growth %: +5.9%
Financial Fact:
Interest income (expense), net: 93K
Today's EPS Names:
KELYA, ROX, KEEL, More
Revenue Growth %: +5.9%
Financial Fact:
Interest income (expense), net: 93K
Today's EPS Names:
KELYA, ROX, KEEL, More
Join SI Premium – FREE
Anika Therapeutics (NASDAQ: ANIK) reported Q4 EPS of $0.05, $0.28 better than the analyst estimate of ($0.23). Revenue for the quarter came in at $43 million versus the consensus estimate of $41.4 million.
GUIDANCE:
Anika Therapeutics sees FY 2024 revenue of $168-173 million, versus the consensus of $179.4 million.
For earnings history and earnings-related data on Anika Therapeutics (ANIK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Loar Holdings Inc. (LOAR) Reports Q3 EPS of $0.39 ; Offers Guidance
- Sempra Energy (SRE) Tops Q3 EPS by 20c ; Offers Guidance
- Ralph Lauren (RL) Tops Q2 EPS by 41c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
